{"organizations": [], "uuid": "0500148c9559c02810971fa7942cece07dc4ff71", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-becton-dickinson-to-divest-remaini/brief-becton-dickinson-to-divest-remaining-investment-in-vyaire-medical-idUSASC09SU8", "country": "US", "domain_rank": 408, "title": "BRIEF-Becton, Dickinson To Divest Remaining Investment In Vyaire Medical", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-19T17:42:00.000+02:00", "replies_count": 0, "uuid": "0500148c9559c02810971fa7942cece07dc4ff71"}, "author": "", "url": "https://www.reuters.com/article/brief-becton-dickinson-to-divest-remaini/brief-becton-dickinson-to-divest-remaining-investment-in-vyaire-medical-idUSASC09SU8", "ord_in_thread": 0, "title": "BRIEF-Becton, Dickinson To Divest Remaining Investment In Vyaire Medical", "locations": [], "entities": {"persons": [{"name": "dickinson", "sentiment": "negative"}, {"name": "vy", "sentiment": "negative"}, {"name": "becton", "sentiment": "none"}], "locations": [{"name": "vyaire", "sentiment": "none"}], "organizations": [{"name": "apax", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 19, 2018 / 3:43 PM / in 9 minutes BRIEF-Becton, Dickinson To Divest Remaining Investment In Vyaire Medical Reuters Staff March 19 (Reuters) - Becton, Dickinson And Co: * BD TO DIVEST REMAINING INVESTMENT IN VYAIRE MEDICAL TO FUNDS MANAGED BY APAX PARTNERS * ‍BD WILL RECEIVE $435 MILLION IN CASH​ * ‍DIVESTITURE WILL NOT HAVE A MATERIAL IMPACT TO BD REVENUE OR ADJUSTED EARNINGS FOR FISCAL 2018​ * ‍EXPECTS TO RECORD A GAIN ON TRANSACTION AT TIME OF CLOSING​ * ‍BD INTENDS TO USE PROCEEDS FROM DEAL IN LINE WITH ITS “BROADER CAPITAL ALLOCATION STRATEGY​” Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-03-19T17:42:00.000+02:00", "crawled": "2018-03-19T17:54:13.027+02:00", "highlightTitle": ""}